-
Loading metrics
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
- Yves Allenbach,
- Marguerite Guiguet,
- Aude Rigolet,
- Isabelle Marie,
- Eric Hachulla,
- Laurent Drouot,
- Fabienne Jouen,
- Serge Jacquot,
- Kuberaka Mariampillai,
- Lucile Musset
x
- Published: November 5, 2015
- https://doi.org/10.1371/journal.pone.0133702